BeiGene Ltd (BGNE) reported a Q4 net loss Thursday of $1.43 per American depositary share, narrowing from $3.53 per share a year earlier.
Analysts polled by FactSet expected a loss of $1.01.
Revenue for the quarter ended Dec. 31 was $1.13 billion, up from $634.4 million a year earlier.
Analysts surveyed by FactSet expected $1.04 billion.
The company expects full year revenue between $4.9 billion and $5.3 billion.
Analysts polled by FactSet expect $4.73 billion.
BeiGene shares were up more than 3% in recent Thursday premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。